Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Blood

• Publication date

  2002-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2001-11-0042PMID 12130492
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lentiviral vectors derived from simian immunodeficiency virus.

  2002cited by this paper
• Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide.

  2002cited by this paper
• Retargeting gene delivery using surface-engineered retroviral vector particles.

  2001cited by this paper
• Sequences in the Cytoplasmic Tail of the Gibbon Ape Leukemia Virus Envelope Protein That Prevent Its Incorporation into Lentivirus Vectors

  2001cited by this paper
• Activation of Membrane Fusion by Murine Leukemia Viruses Is Controlled in cis or in trans by Interactions between the Receptor-Binding Domain and a Conserved Disulfide Loop of the Carboxy Terminus of the Surface Glycoprotein

  2001cited by this paper
• Development of an Avian Leukosis-Sarcoma Virus Subgroup A Pseudotyped Lentiviral Vector

  2001cited by this paper
• Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo

  2001cited by this paper
• Sustained multilineage gene persistence and expression in dogs transplanted with CD34(+) marrow cells transduced by RD114-pseudotype oncoretrovirus vectors.

  2001cited by this paper
• Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors

  2001cited by this paper
• Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap

  2001cited by this paper
• Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins.

  2001cited by this paper
• A Unique Heparin-Binding Domain in the Envelope Protein of the Neuropathogenic PVC-211 Murine Leukemia Virus May Contribute to Its Brain Capillary Endothelial Cell Tropism

  2001cited by this paper
• Engraftment of NOD/SCID Mice with Human CD34+Cells Transduced by Concentrated Oncoretroviral Vector Particles Pseudotyped with the Feline Endogenous Retrovirus (RD114) Envelope Protein

  2001cited by this paper
• Early and Persistent Bone Marrow Hematopoiesis Defect in Simian/Human Immunodeficiency Virus-Infected Macaques despite Efficient Reduction of Viremia by Highly Active Antiretroviral Therapy during Primary Infection

  2001cited by this paper
• Receptor Binding Transforms the Surface Subunit of the Mammalian C-Type Retrovirus Envelope Protein from an Inhibitor to an Activator of Fusion

  2001cited by this paper
• Heparin Inhibits Retrovirus Binding to Fibronectin as Well as Retrovirus Gene Transfer on Fibronectin Fragments

  2001cited by this paper
• Inhibition of release of lentivirus particles with incorporated human influenza virus haemagglutinin by binding to sialic acid-containing cellular receptors.

  2001cited by this paper
• Fibronectin fragment CH-296 inhibits apoptosis and enhances ex vivo gene transfer by murine retrovirus and human lentivirus vectors independent of viral tropism in nonhuman primate CD34+ cells.

  2001cited by this paper
• Retroviral transduction of human CD34+ cells on fibronectin fragment CH‐296 is inhibited by high concentrations of vector containing medium

  2001cited by this paper
• Lipid Rafts and Pseudotyping

  2001cited by this paper
• Transduction of CD34+ cells with lentiviral vectors enables the production of large quantities of transgene‐expressing immature and mature dendritic cells

  2001cited by this paper
• Analysis of 4070A envelope levels in retroviral preparations and effect on target cell transduction efficiency.

  2000cited by this paper
• Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein.

  2000cited by this paper
• Evidence for a Stable Interaction of gp41 with Pr55Gag in Immature Human Immunodeficiency Virus Type 1 Particles

  2000cited by this paper
• Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.

  2000cited by this paper
• Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.

  2000cited by this paper
• Efficient lentiviral transduction of liver requires cell cycling in vivo

  2000cited by this paper
• High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors.

  2000cited by this paper
• Genetic Evidence for an Interaction between Human Immunodeficiency Virus Type 1 Matrix and α-Helix 2 of the gp41 Cytoplasmic Tail

  2000cited by this paper
• Simian immunodeficiency virus resistance of macaques infused with interferon beta-engineered lymphocytes.

  2000cited by this paper
• Simian immunodeficiency virus resistance of macaques infused with interferon β-engineered lymphocytes

  2000cited by this paper
• VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum.

  2000cited by this paper
• Development of Minimal Lentivirus Vectors Derived from Simian Immunodeficiency Virus (SIVmac251) and Their Use for Gene Transfer into Human Dendritic Cells

  2000cited by this paper
• Interdependence of Hemagglutinin Glycosylation and Neuraminidase as Regulators of Influenza Virus Growth: a Study by Reverse Genetics

  2000cited by this paper
• Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells

  2000cited by this paper
• Intracellular Interaction of Simian Immunodeficiency Virus Gag and Env Proteins

  1999cited by this paper
• Modifying the host range properties of retroviral vectors

  1999cited by this paper
• Modulation of Phosphate Uptake and Amphotropic Murine Leukemia Virus Entry by Posttranslational Modifications of PIT-2

  1999cited by this paper
• Retroviral Display of Functional Binding Domains Fused to the Amino Terminus of Influenza Hemagglutinin

  1999cited by this paper
• Initial Binding of Murine Leukemia Virus Particles to Cells Does Not Require Specific Env-Receptor Interaction

  1999cited by this paper
• The Resistance of Retroviral Vectors Produced from Human Cells to Serum Inactivation In Vivo and In Vitro Is Primate Species Dependent

  1999cited by this paper
• Rescue from Photoreceptor Degeneration in therd Mouse by Human Immunodeficiency Virus Vector-Mediated Gene Transfer

  1999cited by this paper
• The Furin Protease Cleavage Recognition Sequence of Sindbis Virus PE2 Can Mediate Virion Attachment to Cell Surface Heparan Sulfate

  1999cited by this paper
• HIV-1 gag proteins: diverse functions in the virus life cycle.

  1998cited by this paper
• High-Level Gene Transfer to Cord Blood Progenitors Using Gibbon Ape Leukemia Virus Pseudotype Retroviral Vectors and an Improved Clinically Applicable Protocol

  1998cited by this paper
• RNA Levels of Human Retrovirus Receptors Pit1 and Pit2 Do Not Correlate with Infectibility by Three Retroviral Vector Pseudotypes

  1998cited by this paper
• High-Titer Human Immunodeficiency Virus Type 1-Based Vector Systems for Gene Delivery into Nondividing Cells

  1998cited by this paper
• Incorporation of Fowl Plague Virus Hemagglutinin into Murine Leukemia Virus Particles and Analysis of the Infectivity of the Pseudotyped Retroviruses

  1998cited by this paper
• Retrovirus-Mediated Gene Transfer into Human CD34+38low Primitive Cells Capable of Reconstituting Long-Term Cultures In Vitro and Nonobese Diabetic–Severe Combined Immunodeficiency Mice In Vivo

  1998cited by this paper
• Synthesis, Assembly, and Processing of Viral Proteins

  1997cited by this paper
• Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors

  1997cited by this paper
• Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation

  1997cited by this paper
• Synthesis, Assembly, and Processing of Viral Proteins -- Retroviruses

  1997cited by this paper
• Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector

  1997cited by this paper
• Cellular proteins in HIV virions

  1997cited by this paper
• Sensitization of cells and retroviruses to human serum by (αl-3) galactosyltransferase

  1996cited by this paper
• In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

  1996cited by this paper
• Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

  1996cited by this paper
• Direct interaction between the envelope and matrix proteins of HIV‐1.

  1996cited by this paper
• Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase.

  1996cited by this paper
• Comparison of Efficiency of Infection of Human Gene Therapy Target Cells via Four Different Retroviral Receptors

  1996cited by this paper
• Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments.

  1996cited by this paper
• A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody

  1995cited by this paper
• High-titer packaging cells producing recombinant retroviruses resistant to human serum

  1995cited by this paper
• Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein

  1994cited by this paper
• Generation of high-titer pseudotyped retroviral vectors with very broad host range.

  1994cited by this paper
• Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity

  1994cited by this paper
• Alphavirus expression systems.

  1994cited by this paper
• Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell

  1994cited by this paper
• Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.

  1994cited by this paper
• pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry

  1994cited by this paper
• Retroviral pseudotypes produced by rescue of a Moloney murine leukemia virus vector by C-type, but not D-type, retroviruses.

  1992cited by this paper
• Sequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-inducing viruses

  1990cited by this paper
• Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells.

  1988cited by this paper
• Study of receptors for vesicular stomatitis virus in vertebrate and invertebrate cells.

  1986cited by this paper

• From Ex Vivo to In Vivo: Advances in Lentiviral Vector Engineering for CAR-T Therapy.

  2026cites this paper
• Challenges and Opportunities in Lentivirus Viral Vector Manufacturing for In Vivo Applications.

  2026cites this paper
• Baboon endogenous retrovirus (ERV) envelope pseudotyped lentiviral vectors outperform human ERV lentivectors for transduction of T, B, NK and HSPCs.

  2026cites this paper
• Hijacking exosome biogenesis: viral glycoproteins as modular scaffolds for engineering functionalized extracellular vesicles

  2026cites this paper
• Retroviral Vector Technology for Gene Therapy: History, Current Landscape, and Future Prospects.

  2025cites this paper
• Combination of targeted pharmacotherapy and immunotherapy with anti‐CD19 CAR NK cells in acute lymphoblastic leukemia

  2025cites this paper
• The Era of Gene Therapy: The Advancement of Lentiviral Vectors and Their Pseudotyping

  2025cites this paper
• Development of Lentiviral Packaging Cells and Scale Up of Production to Meet the Growing Demand in Cell and Gene Therapy.

  2025cites this paper
• Targeted gene delivery systems for T-cell engineering

  2024cites this paper
• The low-density lipoprotein receptor and apolipoprotein E associated with CCHFV particles mediate CCHFV entry into cells

  2024cites this paper
• Development and utility of a SARS-CoV-2 pseudovirus assay for compound screening and antibody neutralization assays

  2024cites this paper
• Development of KoRV-pseudotyped lentiviral vectors for efficient gene transfer into freshly isolated immune cells

  2024cites this paper
• Pseudoviruses, a safer toolbox for vaccine development against enveloped viruses

  2024cites this paper
• Design and Application of Biosafe Coronavirus Engineering Systems without Virulence

  2024cites this paper
• Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer

  2024cites this paper
• Development of HIV-1 vectors pseudotyped with envelope proteins of other retroviruses.

  2024cites this paper
• Genetic Manipulation Approaches to Enhance the Clinical Application of NK Cell-Based Immunotherapy

  2023cites this paper
• Optimized peptide nanofibrils as efficient transduction enhancers for in vitro and ex vivo gene transfer

  2023cites this paper
• Pseudotyped Viruses for Marburgvirus and Ebolavirus.

  2023cites this paper
• Pseudotyped Viruses.

  2023cites this paper
• DC-targeting lentivectors for cancer immunotherapy

  2023cites this paper
• CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma

  2023cites this paper
• Primary T‐cell‐based delivery platform for in vivo synthesis of engineered proteins

  2023cites this paper
• Simultaneous engineering of natural killer cells for CAR transgenesis and CRISPR-Cas9 knockout using retroviral particles.

  2023cites this paper
• Genetic modification of adipose-derived stem cells for bone regeneration

  2022cites this paper
• Manufacturing of CAR-T Cells: The Assembly Line

  2022cites this paper
• Clinical grade lentiviral vector purification and quality control requirements.

  2022cites this paper
• Broad Tricyclic Ring Inhibitors Block SARS-CoV-2 Spike Function Required for Viral Entry

  2022cites this paper
• Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies

  2022influential citation
• Gene-Based Natural Killer Cell Therapies for the Treatment of Pediatric Hematologic Malignancies.

  2022cites this paper
• Generation of an NFκB-Driven Alpharetroviral “All-in-One” Vector Construct as a Potent Tool for CAR NK Cell Therapy

  2021cites this paper
• Lentiviral Vector Bioprocessing

  2021cites this paper
• Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases

  2021cites this paper
• More Than Just Gene Therapy Vectors: Lentiviral Vector Pseudotypes for Serological Investigation

  2021cites this paper
• Telomerase Reverse Transcriptase Increases Proliferation and Lifespan of Human NK Cells without Immortalization

  2021cites this paper
• Increased Susceptibility of the CD57− NK Cells Expressing KIR2DL2/3 and NKG2C to iCasp9 Gene Retroviral Transduction and the Relationships with Proliferative Potential, Activation Degree, and Death Induction Response

  2021cites this paper
• HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for “Off-the-Shelf” Immunotherapy

  2021cites this paper
• Exploiting B Cell Transfer for Cancer Therapy: Engineered B Cells to Eradicate Tumors

  2021cites this paper
• Towards Physiologically and Tightly Regulated Vectored Antibody Therapies

  2020cites this paper
• The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity and decreases neutralization sensitivity to individual convalescent sera

  2020cites this paper
• Gene therapy

  2020cites this paper
• Improved SARS-CoV-2 Spike Glycoproteins for Pseudotyping Lentiviral Vectors

  2020influential citation
• High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia

  2020cites this paper
• Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity.

  2020cites this paper
• D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity

  2020cites this paper
• Toward Tightly Tuned Gene Expression Following Lentiviral Vector Transduction

  2020cites this paper
• Gene Therapy Applications of Non-Human Lentiviral Vectors

  2020cites this paper
• Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2

  2020cites this paper
• Identifying Biomarkers of Autophagy and Apoptosis in Transfected Nuclear Donor Cells and Transgenic Cloned Pig Embryos

  2019cites this paper
• Efficient and Robust NK-Cell Transduction With Baboon Envelope Pseudotyped Lentivector

  2019cites this paper
• Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo

  2019cites this paper
• Toward a Scalable Purification Protocol of GaLV-TR-Pseudotyped Lentiviral Vectors

  2019cites this paper
• Generation of a neutralizing antibody against RD114-pseudotyped viral vectors.

  2019cites this paper
• Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes

  2019cites this paper
• Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing

  2019cites this paper
• Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency.

  2019cites this paper
• Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity

  2019cites this paper
• Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility

  2019cites this paper
• Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering

  2019cites this paper
• Differential Roles of Lipin1 and Lipin2 in the Hepatitis C Virus Replication Cycle

  2019cites this paper
• Progressing from transient to stable packaging cell lines for continuous production of lentiviral and gammaretroviral vectors

  2018cites this paper
• 3 Surface Modification of Retroviral Vectors for Gene Therapy

  2018cites this paper
• CD46 Null Packaging Cell Line Improves Measles Lentiviral Vector Production and Gene Delivery to Hematopoietic Stem and Progenitor Cells

  2018cites this paper
• A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism

  2018cites this paper
• Decisional tools for cost-effective bioprocess design for cell therapies and patient-specific drug discovery tools

  2018cites this paper
• Lentivector Producer Cell Lines with Stably Expressed Vesiculovirus Envelopes

  2018cites this paper
• Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry

  2018cites this paper
• Direct Visualization of the Conformational Dynamics of Single Influenza Hemagglutinin Trimers.

  2018cites this paper
• Industrializing Autologous Adoptive Immunotherapies: Manufacturing Advances and Challenges

  2018cites this paper
• Vesiculovirus G protein-based stable cell lines for continuous lentiviral vector production

  2018cites this paper
• The interferon inducible isoform of NCOA7 inhibits endosome-mediated viral entry

  2018cites this paper
• Envelope glycoproteins of vesiculoviruses : characteristics of antibody interactions and immunogenicity

  2018influential citation
• A reproducible method for the isolation and expansion of ovine mesenchymal stromal cells from bone marrow for use in regenerative medicine preclinical studies

  2017cites this paper
• Detailed comparison of retroviral vectors and promoter configurations for stable and high transgene expression in human induced pluripotent stem cells

  2017cites this paper
• Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes

  2017cites this paper
• Lentiviral Vectors Pseudotyped with Filoviral Glycoproteins.

  2017cites this paper
• Lentiviral vector packaging cell line development using genome editing to target optimal loci discovered by high throughput DNA barcoding

  2017cites this paper
• Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration

  2017cites this paper
• How have retrovirus pseudotypes contributed to our understanding of viral entry

  2017cites this paper
• Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.

  2017cites this paper
• Pseudotyped Lentiviral Vectors: One Vector, Many Guises

  2017cites this paper
• Gene editing as an alternative to retroviral vectors for wiskott-aldrich syndrome gene therapy

  2017cites this paper
• Vectofusin-1, a potent peptidic enhancer of viral gene transfer forms pH-dependent α-helical nanofibrils, concentrating viral particles.

  2017influential citation
• Codon Optimization Leads to Functional Impairment of RD114-TR Envelope Glycoprotein

  2017cites this paper
• Improvement of De Novo Cholesterol Biosynthesis Efficiently Promotes the Production of Human Immunodeficiency Virus Type 1-Derived Lentiviral Vectors

  2017cites this paper
• Microfluidic Transduction Harnesses Mass Transport Principles to Enhance Gene Transfer Efficiency

  2017cites this paper
• Current status on the development of pseudoviruses for enveloped viruses

  2017cites this paper
• Generation of Induced Pluripotent Stem Cells in Rabbits.

  2016cites this paper
• Pseudotyping of lentiviral vector with novel vesiculovirus envelope glycoproteins derived from Chandipura and Piry viruses.

  2016cites this paper
• Production of Retrovirus-Based Vectors in Mildly Acidic pH Conditions.

  2016cites this paper
• RD-MolPack technology for the constitutive production of self-inactivating lentiviral vectors pseudotyped with the nontoxic RD114-TR envelope

  2016cites this paper
• Baboon envelope pseudotyped lentiviral vectors efficiently transduce human B cells and allow active factor IX B cell secretion in vivo in NOD/SCIDγc‐/‐ mice

  2016cites this paper
• Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapy

  2016cites this paper
• A Novel Generation of Lentiviral Vectors for Gene Therapy

  2016cites this paper
• Retroviral vector interactions with hematopoietic cells.

  2016cites this paper
• Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector Platform.

  2016cites this paper
• Primate TRIM5 proteins form hexagonal nets on HIV-1 capsids

  2016cites this paper
• Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes.

  2016cites this paper
• Progresses towards safe and efficient gene therapy vectors

  2015cites this paper
• Impacts of human LDLR overexpression on the production of a VSVG-pseudotyped lentiviral vector

  2015cites this paper